DNA methylation of cancer genome
Citations Over TimeTop 10% of 2009 papers
Abstract
DNA methylation plays an important role in regulating normal development and carcinogenesis. Current understanding of the biological roles of DNA methylation is limited to its role in the regulation of gene transcription, genomic imprinting, genomic stability, and X chromosome inactivation. In the past 2 decades, a large number of changes have been identified in cancer epigenomes when compared with normals. These alterations fall into two main categories, namely, hypermethylation of tumor suppressor genes and hypomethylation of oncogenes or heterochromatin, respectively. Aberrant methylation of genes controlling the cell cycle, proliferation, apoptosis, metastasis, drug resistance, and intracellular signaling has been identified in multiple cancer types. Recent advancements in whole-genome analysis of methylome have yielded numerous differentially methylated regions, the functions of which are largely unknown. With the development of high resolution tiling microarrays and high throughput DNA sequencing, more cancer methylomes will be profiled, facilitating the identification of new candidate genes or ncRNAs that are related to oncogenesis, new prognostic markers, and the discovery of new target genes for cancer therapy.
Related Papers
- → DNA methylation in osteoarthritic chondrocytes: a new molecular target(2006)78 cited
- → Genetic and Environmental Impacts on DNA Methylation Levels in Twins(2015)39 cited
- → Changes of DNA methylation of Isoetes sinensis under Pb and Cd stress(2018)15 cited
- → Early Nutritional Influences on Human Developmental Epigenetics(2015)
- [Tobacco and DNA methylation: the case for epigenetic alterations].(2021)